BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

437 related articles for article (PubMed ID: 14051502)

  • 21. EFFECT OF INTRACELLULAR REDOX ENVIRONMENT ON BACTERICIDAL ACTION OF MITOMYCIN C AND STREPTONIGRIN.
    WHITE JR; WHITE HL
    Antimicrob Agents Chemother (Bethesda); 1964; 10():495-9. PubMed ID: 14287983
    [No Abstract]   [Full Text] [Related]  

  • 22. COMPARATIVE PHARMACOLOGY OF ALKYLATING AGENTS. I.
    SCHMIDT LH; FRADKIN R; SULLIVAN R; FLOWERS A
    Cancer Chemother Rep; 1965 Jan; 18():SUPPL 2:1-401. PubMed ID: 14278901
    [No Abstract]   [Full Text] [Related]  

  • 23. [EXPERIMENTAL STUDIES ON BIOLOGICAL PROPERTIES OF THE ANTIBIOTIC 14725 FROM THE OSTREOGRISIN GROUP].
    PEVZNER NS; SHAPOVALOVA SP; BELOVA IP
    Antibiotiki; 1964 Sep; 9():828-32. PubMed ID: 14341264
    [No Abstract]   [Full Text] [Related]  

  • 24. [HISTOPATHOLOGICAL CHANGES IN ANIMAL ORGANS AND TISSUES FOLLOWING THE ADMINISTRATION OF RISTOMYCIN].
    BELOVA IP
    Antibiotiki; 1963 May; 8():414-7. PubMed ID: 14077203
    [No Abstract]   [Full Text] [Related]  

  • 25. ISOLATION AND CHARACTERIZATION OF LEMONOMYCIN, A NEW ANTIBIOTIC.
    WHALEY HA; PATTERSON EL; DANN M; SHAY AJ; PORTER JN
    Antimicrob Agents Chemother (Bethesda); 1964; 14():83-6. PubMed ID: 14289713
    [No Abstract]   [Full Text] [Related]  

  • 26. [STUDY IN ANIMALS OF PRISTINAMYCIN (7293 RP) CONSTITUENTS].
    BENAZET F; COSAR C
    Ann Inst Pasteur (Paris); 1965 Aug; 109():281-9. PubMed ID: 14336048
    [No Abstract]   [Full Text] [Related]  

  • 27. BACTERIOSTATIC CHEMOTHERAPEUTIC AND MALIGNANT TUMOR GROWTH; CHANGE OF BLOOD CATALASE ACTIVITY UNDER PROLONGED ADMINISTRATION OF BACTERIOSTATIC CHEMOTHERAPEUTIC.
    HIRATA M
    Hiroshima J Med Sci; 1964 Mar; 13():17-27. PubMed ID: 14276060
    [No Abstract]   [Full Text] [Related]  

  • 28. PREDICTION OF STABILITY IN PAHRMACEUTICAL PREPARATIONS. 13. STABILITY, SPECTROPHOTOMETRIC , AND BIOLOGICAL ASSAY OF THE ANTIBIOTIC PORFIROMYCIN IN PHARMACEUTICALLY USEFUL PH RANGES.
    GARRETT ER; SCHROEDER W
    J Pharm Sci; 1964 Aug; 53():917-23. PubMed ID: 14241805
    [No Abstract]   [Full Text] [Related]  

  • 29. STREPTOZOTOCIN.
    WHITE FR
    Cancer Chemother Rep; 1963 Jul; 30():49-53. PubMed ID: 14051504
    [No Abstract]   [Full Text] [Related]  

  • 30. CHEMICAL NATURE AND BIOSYNTHESIS OF STREPTOLYSIN S'.
    KOYAMA J; SOKAWA Y; EGAMI F
    Biochem Z; 1963; 338():206-16. PubMed ID: 14087293
    [No Abstract]   [Full Text] [Related]  

  • 31. EVERNINOMICIN, A NEW ANTIBIOTIC COMPLEX FROM MICROMONOSPORA CARBONACEA.
    WEINSTEIN MJ; LUEDEMANN GM; ODEN EM; WAGMAN GH
    Antimicrob Agents Chemother (Bethesda); 1964; 10():24-32. PubMed ID: 14287938
    [No Abstract]   [Full Text] [Related]  

  • 32. ANIMAL TOXICITY STUDIES OF A NEW ANTIBIOTIC, LINCOMYCIN.
    GRAY JE; PURMALIS A; FEENSTRA ES
    Toxicol Appl Pharmacol; 1964 Jul; 6():476-96. PubMed ID: 14223498
    [No Abstract]   [Full Text] [Related]  

  • 33. COMPARATIVE PHARMACOLOGY OF ALKYLATING AGENTS. II. THERAPEUTIC ACTIVITIES OF ALKYLATING AGENTS AND REFERENCE COMPOUNDS AGAINST VARIOUS TUMOR SYSTEMS.
    SCHMIDT LH; FRADKIN R; SULLIVAN R; FLOWERS A
    Cancer Chemother Rep; 1965 Jan; 18():SUPPL 2:403+. PubMed ID: 14278902
    [No Abstract]   [Full Text] [Related]  

  • 34. ANTIBIOTIC MSD-235. 3. EVALUATION OF ANTIBIOTIC MSD-235 IN VITRO AND IN EXPERIMENTAL INFECTIONS IN MICE.
    MILLER AK
    Antimicrob Agents Chemother (Bethesda); 1963; 161():33-7. PubMed ID: 14274921
    [No Abstract]   [Full Text] [Related]  

  • 35. BACTERIOSTATIC CHEMOTHERAPEUTIC AND MALIGNANT TUMOR GROWTH; CHANGE OF SERUM MUCOPROTEIN LEVEL UNDER PROLONGED ADMINISTRATION OF BACTERIOSTATIC CHEMOTHERAPEUTIC.
    HIRATA M
    Hiroshima J Med Sci; 1964 Mar; 13():29-39. PubMed ID: 14276062
    [No Abstract]   [Full Text] [Related]  

  • 36. GENTAMICIN, A NEW BROAD-SPECTRUM ANTIBIOTIC COMPLEX.
    WEINSTEIN MJ; LUEDEMANN GM; ODEN EM; WAGMAN GH
    Antimicrob Agents Chemother (Bethesda); 1963; 161():1-7. PubMed ID: 14274893
    [No Abstract]   [Full Text] [Related]  

  • 37. Resistance and cross-resistance of Escherichia coli mutants to antitumour agent mitomycin C.
    GREENBERG J; MANDELL JD; WOODY PL
    J Gen Microbiol; 1961 Nov; 26():509-20. PubMed ID: 13901477
    [No Abstract]   [Full Text] [Related]  

  • 38. RUBIFLAVIN, A TOXIC ANTITUMOR ANTIBIOTIC.
    ASZALOS A; JELINEK M; BERK B
    Antimicrob Agents Chemother (Bethesda); 1964; 10():68-74. PubMed ID: 14288020
    [No Abstract]   [Full Text] [Related]  

  • 39. Studies on mitomycin C, especially method of administration.
    HATA T; HOSSENLOPP C; TAKITA H
    Cancer Chemother Rep; 1961 Jul; 13():67-77. PubMed ID: 13712204
    [No Abstract]   [Full Text] [Related]  

  • 40. Liquid chromatography-thermospray mass spectrometry of DNA adducts formed with mitomycin C, porfiromycin and thiotepa.
    Musser SM; Pan SS; Callery PS
    J Chromatogr; 1989 Jul; 474(1):197-207. PubMed ID: 2504760
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.